HRTX News and Press, Heron Therapeutics Inc. From 03/21/20

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

Noteworthy events during the week of March 22 - 28 for healthcare investors (some could be canceled/postponed due to COVID-19). More news on: Bristol-Myers Squibb Company, Zogenix, Inc., Heron Therapeutics, Inc., Healthcare stocks news, , Read more ...

Business disruptions due to COVID-19 represent a new risk for investors across all sectors. Expect to see language addressing this added to the risk factors section of 10-K annual reports filed with the Securities and Exchange Commission (SEC). For biotech and pharma companies, COVID-19 will im...

SAN DIEGO , Feb. 25, 2020 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced tha...

Investment Thesis Heron Therapeutics ( HRTX ) had a mixed year in 2019 and in my view some of the problems the company encountered are likely to continue to be felt through 2020 and perhaps beyond. This makes me concerned for the price of the company's stock. The three main issues the co...

Heron Therapeutics ( HRTX ) has been made its way onto my watch list a few times over the past couple of years and I have always found an excuse to hold off on starting a position. Admittedly, I haven’t checked on the ticker since HTX-011 received its CRL back in May of 2019. Now, I a...

SAN DIEGO , Feb. 19, 2020 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced tha...

SAN DIEGO , Feb. 18, 2020 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced tha...

Nothing provides greater stock price swings in the biotech sector than late-stage clinical trial results and drug approval decisions from the U.S. Food and Drug Administration. A recent research report from investment bank Jefferies (NYSE: JEF)  listed key biotech events for the coming q...

December 17, 2019 Palm Beach, FL –December 17, 2019 – The success rate for cancer therapies has been limited due to a combination of factors, such as  the treatment/drug’s lack of penetration through the blood brain barrier. Reports say that the global drug d...